These patients may develop autoantibodies against the coagulation factors VIII and IX leading to the acquired form of hemophilia A or B [29], or develop immune thrombocytopenia as a result of increased turnover or reduced production of platelets [30]. This evidence concerns the gene F8 and autoimmune thrombocytopenic purpura.